Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Wall Street Opens Mixed as J&J Shock Dents Reopening Trades - Dow Down 150 Pts

Published 13/04/2021, 14:31
Updated 13/04/2021, 14:34
© Reuters.

By Geoffrey Smith 

Investing.com -- U.S. stock markets opened mixed on Tuesday after news that the U.S. will suspend the distribution of Johnson & Johnson (NYSE:JNJ)'s Covid-19 vaccine wrongfooted the reopening trades that have dominated in recent weeks. 

"We are recommending a pause in the use of this vaccine out of an abundance of caution," the Food and Drug Administration said in a joint statement with the Center for Disease Control and Prevention on Twitter. The move comes after six patients - all of them women aged between 18 and 48, developed blood clots on the brain within two weeks of taking the vaccine. The problem is similar to the one that has dogged AstraZeneca (NASDAQ:AZN)'s Covid-19 drug, although the incidence appears to be lower: the six cases identified compare to over 6.8 million shots of the J&J drug already distributed.

J&J said it will proactively stop the rollout of the drug in Europe. J&J stock fell 2.4%, dragging down popular 'reopening'-themed stocks such as airlines and cruise operators. American Airlines (NASDAQ:AAL) stock was the worst affected, falling 5.1%, while United Airlines (NASDAQ:UAL) stock fell 3.6%. Both airlines have chosen to tap relatively expensive debt markets in recent weeks to get them through what they expect to be the last of the Covid-19-related lockdowns, rather than depend on cheaper funding from the government that comes with more strings attached. Carnival  (NYSE:CCL) stock meanwhile fell 2.6% 

Some of the biggest gainers from the news were rival vaccine makers, which now have an opportunity to grab market share from J&J. Moderna (NASDAQ:MRNA) stock rose 8.9%, while BioNTech SE (NASDAQ:BNTX) stock rose 7.2%.

The news overshadowed a slightly higher-than-expected inflation print for March. The CPI rose 2.6% year-on-year as the collapse of oil prices a year ago created a distorted base effect. The monthly rise in prices, at 0.3%, was however also stronger than expected and the biggest such rise since September. 

By 9:40 AM ET (1340 GMT), the Dow Jones Industrial Average was down 180 points, or 0.5%, at 33,565 points. The S&P 500 was down 0.1% but the NASDAQ Composite was up 0.8%.

"US inflation is on the rise and has a lot further to go. We see 4% in the next few months with rising corporate pricing power and the strong housing market likely to keep it close to 3% for much longer than the market is anticipating," said James Knightley, chief international economist with ING, via Twitter.

Elsewhere, Altimeter Growth Corp (NASDAQ:AGC)., the special purpose acquisition company that has agreed to take southeast Asian ride-hailing company Grab public at a valuation of $40 billon, fell some 4.7% after initially rising on the reports. 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.